Medicure Inc.
1200 Waverley Street
Suite 4
Winnipeg
Manitoba
R3T 0P4
Canada
Tel: 204-487-7412 or 888-435-2220
Fax: 204-488-9823
Website: http://www.medicureinc.com/
Email: info@medicureinc.com
229 articles about Medicure Inc.
-
Medicure Closes Acquisition Of Majority Interest In Apicore LLC
12/1/2016
-
Medicure Exercises Option To Acquire Majority Interest In Apicore LLC
11/18/2016
-
Medicure Reports Third Quarter 2016 Financial Results
11/11/2016
-
Medicure To Announce Q3 2016 Financial Results On November 9, 2016
11/3/2016
-
Medicure Release: FDA Approves New AGGRASTAT Product Format
9/1/2016
-
Medicure Reports Second Quarter 2016 Financial Results
8/11/2016
-
Medicure Receives Response Letter From FDA On AGGRASTAT sNDA For New Indication
7/8/2016
-
Medicure Files Application For New AGGRASTAT Product Format
5/11/2016
-
Medicure COO Terminated, Effective Immediately
5/10/2016
-
Medicure Inc. Announces Upcoming Conference Presentations
4/5/2016
-
Medicure Inc. Reports Financial Results For Quarter And Year Ended December 31, 2015
3/31/2016
-
Medicure Inc. To Announce Fiscal Year 2015 Financial Results on March 30, 2016
3/24/2016
-
Medicure Inc. Release: Meta-Analysis Of AGGRASTAT (Tirofiban HCL) Presented At CRT 2016 Conference
2/23/2016
-
Medicure Inc. To Present At Cantech Investment Conference
1/21/2016
-
Medicure Inc. Announces ANDA Collaboration With Apicore
1/6/2016
-
Medicure Inc. Announces PDUFA Action Date For New Aggrastat Indication
12/2/2015
-
Medicure Inc. Announces Grant Of Stock Options
11/30/2015
-
Medicure Inc. Reports Third Quarter 2015 Financial Results
11/10/2015
-
Medicure Inc. Reports Financial Results For The First Quarter Of 2015
4/30/2015
-
Medicure Inc. Q1 Results And Conference Call Dates
4/24/2015